STI571
Drug timelines are a Plus or Pro feature.
8 regulatory and trial events tracked for STI571, covering 2007-08-03 to 2021-07-22. Get the full timeline:
Most recent: Clinical Trial Update: An Extension Study to Determine the Efficacy and Safety of STI571 in Participants With Chronic Myeloid Leukemia Who Are Refractory to or Intolerant of Interferon-Alpha [Phase 2]